REBEAUT Trademark

Trademark Overview

On Friday, February 19, 2021, a trademark application was filed for REBEAUT with the United States Patent and Trademark Office. The USPTO has given the REBEAUT trademark a serial number of 90536502. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, June 28, 2024. This trademark is owned by Ponce Therapeutics Inc.. The REBEAUT trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders
rebeaut

General Information

Serial Number90536502
Word MarkREBEAUT
Filing DateFriday, February 19, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements

Goods and ServicesGene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePonce Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154
Party NamePonce Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events

Event DateEvent Description
Tuesday, February 23, 2021NEW APPLICATION ENTERED
Friday, May 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Saturday, September 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 22, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 22, 2022SOU EXTENSION 1 FILED
Wednesday, June 22, 2022SOU EXTENSION 1 GRANTED
Friday, June 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 24, 2022SOU TEAS EXTENSION RECEIVED
Saturday, December 24, 2022SOU EXTENSION 2 FILED
Saturday, December 24, 2022SOU EXTENSION 2 GRANTED
Tuesday, December 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 3 FILED
Tuesday, June 27, 2023SOU EXTENSION 3 GRANTED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 20, 2023SOU EXTENSION 4 FILED
Wednesday, December 20, 2023SOU EXTENSION 4 GRANTED
Friday, December 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU EXTENSION 5 FILED
Friday, June 28, 2024SOU EXTENSION 5 GRANTED

Related Keywords

rebeaut other cancer related skin disorders treatment prevention therapy based pharmaceutical